AMPH
Price
$29.39
Change
-$1.42 (-4.61%)
Updated
Sep 3 closing price
Capitalization
1.43B
67 days until earnings call
AYTU
Price
$2.34
Change
-$0.01 (-0.43%)
Updated
Sep 3 closing price
Capitalization
21.01M
Interact to see
Advertisement

AMPH vs AYTU

Header iconAMPH vs AYTU Comparison
Open Charts AMPH vs AYTUBanner chart's image
Amphastar Pharmaceuticals
Price$29.39
Change-$1.42 (-4.61%)
Volume$567.06K
Capitalization1.43B
Aytu BioPharma
Price$2.34
Change-$0.01 (-0.43%)
Volume$30.95K
Capitalization21.01M
AMPH vs AYTU Comparison Chart in %
Loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AYTU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMPH vs. AYTU commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a Buy and AYTU is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (AMPH: $29.39 vs. AYTU: $2.34)
Brand notoriety: AMPH and AYTU are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMPH: 107% vs. AYTU: 22%
Market capitalization -- AMPH: $1.43B vs. AYTU: $21.01M
AMPH [@Pharmaceuticals: Generic] is valued at $1.43B. AYTU’s [@Pharmaceuticals: Generic] market capitalization is $21.01M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.55B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 0 FA rating(s) are green whileAYTU’s FA Score has 0 green FA rating(s).

  • AMPH’s FA Score: 0 green, 5 red.
  • AYTU’s FA Score: 0 green, 5 red.
According to our system of comparison, both AMPH and AYTU are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 3 TA indicator(s) are bullish while AYTU’s TA Score has 6 bullish TA indicator(s).

  • AMPH’s TA Score: 3 bullish, 7 bearish.
  • AYTU’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, AYTU is a better buy in the short-term than AMPH.

Price Growth

AMPH (@Pharmaceuticals: Generic) experienced а -3.61% price change this week, while AYTU (@Pharmaceuticals: Generic) price change was +0.43% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.02%. For the same industry, the average monthly price growth was +9.86%, and the average quarterly price growth was +87.27%.

Reported Earning Dates

AMPH is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.02% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMPH($1.43B) has a higher market cap than AYTU($21M). AYTU YTD gains are higher at: 37.647 vs. AMPH (-20.846). AMPH has higher annual earnings (EBITDA): 248M vs. AYTU (10.6M). AMPH has more cash in the bank: 232M vs. AYTU (18.2M). AYTU has less debt than AMPH: AYTU (21.4M) vs AMPH (655M). AMPH has higher revenues than AYTU: AMPH (723M) vs AYTU (81.7M).
AMPHAYTUAMPH / AYTU
Capitalization1.43B21M6,824%
EBITDA248M10.6M2,340%
Gain YTD-20.84637.647-55%
P/E Ratio11.54N/A-
Revenue723M81.7M885%
Total Cash232M18.2M1,275%
Total Debt655M21.4M3,061%
FUNDAMENTALS RATINGS
AMPH vs AYTU: Fundamental Ratings
AMPH
AYTU
OUTLOOK RATING
1..100
2212
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
42
Fair valued
PROFIT vs RISK RATING
1..100
82100
SMR RATING
1..100
4885
PRICE GROWTH RATING
1..100
4140
P/E GROWTH RATING
1..100
7966
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AYTU's Valuation (42) in the Other Consumer Services industry is in the same range as AMPH (66) in the Pharmaceuticals Other industry. This means that AYTU’s stock grew similarly to AMPH’s over the last 12 months.

AMPH's Profit vs Risk Rating (82) in the Pharmaceuticals Other industry is in the same range as AYTU (100) in the Other Consumer Services industry. This means that AMPH’s stock grew similarly to AYTU’s over the last 12 months.

AMPH's SMR Rating (48) in the Pharmaceuticals Other industry is somewhat better than the same rating for AYTU (85) in the Other Consumer Services industry. This means that AMPH’s stock grew somewhat faster than AYTU’s over the last 12 months.

AYTU's Price Growth Rating (40) in the Other Consumer Services industry is in the same range as AMPH (41) in the Pharmaceuticals Other industry. This means that AYTU’s stock grew similarly to AMPH’s over the last 12 months.

AYTU's P/E Growth Rating (66) in the Other Consumer Services industry is in the same range as AMPH (79) in the Pharmaceuticals Other industry. This means that AYTU’s stock grew similarly to AMPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHAYTU
RSI
ODDS (%)
Bearish Trend 1 day ago
61%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 11 days ago
75%
Declines
ODDS (%)
Bearish Trend 18 days ago
71%
Bearish Trend 18 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
56%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AYTU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QICLX16.790.04
+0.24%
AQR International Multi-Style I
NWXUX11.34N/A
N/A
Nationwide International Sm Cp R6
LAVPX16.07N/A
N/A
Lord Abbett Fundamental Equity P
VOLMX24.10N/A
N/A
Volumetric
JVASX40.08N/A
N/A
JPMorgan Value Advantage I

AMPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with COLL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then COLL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
-4.61%
COLL - AMPH
39%
Loosely correlated
+1.05%
AMRX - AMPH
36%
Loosely correlated
-0.42%
ZTS - AMPH
33%
Poorly correlated
-0.29%
HROW - AMPH
31%
Poorly correlated
-1.01%
BHC - AMPH
30%
Poorly correlated
-4.30%
More

AYTU and

Correlation & Price change

A.I.dvisor tells us that AYTU and AMPH have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AYTU and AMPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AYTU
1D Price
Change %
AYTU100%
-0.43%
AMPH - AYTU
29%
Poorly correlated
-4.61%
TRUFF - AYTU
22%
Poorly correlated
+2.58%
IMCC - AYTU
21%
Poorly correlated
-8.11%
PBH - AYTU
21%
Poorly correlated
+0.62%
BHC - AYTU
21%
Poorly correlated
-4.30%
More